SBRA
Sabra Healthcare REIT Inc
18.70$
-2.0%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +1.5% | +2.1% | +5.6% | +1.1% | +2.4% | +0.7% | +3.1% | +0.5% | +11.5% | +4.6% | +6.4% | – | |
| – | +1.5% | +8.3% | +1.4% | +6.9% | +2.3% | +0.2% | +2.0% | +14.0% | +15.5% | +6.5% | +7.7% | – | |
| – | +1.5% | -0.7% | +7.7% | -1.6% | +2.5% | +0.9% | +3.6% | -6.0% | +9.2% | +3.5% | +73.3% | – | |
| – | +55.0% | -28.7% | +7.2% | -2.6% | +5.1% | -2.3% | -1.7% | +0.4% | +26.7% | -6.6% | +13.2% | – | |
| – | +450.2% | -7.4% | -0.7% | +1.3% | +0.2% | +1.8% | -0.2% | +8.4% | +10.0% | +44.4% | +208.1% | – | |
| – | -46.3% | +6.7% | +15.6% | -3.9% | +4.5% | +0.1% | +6.8% | -17.2% | +8.4% | -38.9% | -256.6% | – | |
| – | +54.6% | -34.8% | +3.2% | +0.5% | -4.7% | -3.5% | +1.7% | +12.6% | -6.7% | -1.8% | +4.8% | – | |
| – | – | +51.3% | -8.6% | +20.9% | +59.5% | -13.5% | +62.2% | -65.2% | +20.4% | +42.7% | -168.0% | – | |
| – | +8.4% | -8.1% | -3.5% | -160.6% | – | +8.7% | +20.3% | -12.3% | +12.6% | +7.1% | -393.9% | – | |
| – | – | +53.0% | -8.7% | +24.2% | +56.8% | -13.7% | +62.6% | -65.6% | +20.8% | +50.2% | -161.6% | – | |
| – | -12.5% | +10.8% | -2.7% | +6.6% | +23.1% | -11.1% | +23.2% | -26.8% | +7.6% | +12.0% | -75.5% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.